Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-15 Orwin John A Director Grant or award · Employee stock option (right to buy) +9,000 9,000
2020-05-15 Meckler Jeffrey A Director Grant or award +3,000 64,000
2020-05-15 Meckler Jeffrey A Director Grant or award · Employee stock option (right to buy) +9,000 9,000
2020-05-15 LYONS GARY A Director Grant or award +3,000 34,000
2020-05-15 LYONS GARY A Director Grant or award · Employee stock option (right to buy) +9,000 9,000
2020-05-15 COUGHLIN TIMOTHY Director Grant or award +3,000 32,000
2020-05-15 COUGHLIN TIMOTHY Director Grant or award · Employee stock option (right to buy) +9,000 9,000
2020-05-15 Poole Sandra Director Grant or award +3,000 6,500
2020-05-15 Poole Sandra Director Grant or award · Employee stock option (right to buy) +9,000 9,000
2020-05-15 ASELAGE STEVE Director Grant or award +3,000 248,732
2020-05-15 ASELAGE STEVE Director Grant or award · Employee stock option (right to buy) +9,000 9,000
2020-05-15 Baynes Roy D. Director Grant or award +3,000 14,000
2020-05-15 Baynes Roy D. Director Grant or award · Employee stock option (right to buy) +9,000 9,000
2020-05-14 ASELAGE STEVE Director Sale −3,062 $15.09 $46K 245,732
2020-05-13 ASELAGE STEVE Director Sale −4,063 $16.41 $67K 248,794
2020-05-12 ASELAGE STEVE Director Sale −1,000 $17.16 $17K 252,857
2020-05-12 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −525 $17.16 $9K 25,958
2020-05-12 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −527 $16.98 $9K 25,431
2020-05-12 ROTE WILLIAM E. Senior Vice President, R&D Sale −812 $17.16 $14K 24,021
2020-05-12 ROTE WILLIAM E. Senior Vice President, R&D Sale −527 $16.98 $9K 23,494

Page 42 of 51 · 1,020 trades